Tanta university
Tanta, Egypt
NCT Number: NCT06933030
The aim of the present study is to assess the customized 3D zirconium versus titanium mesh for anterior maxillary ridge augmentation with delayed implant placement.
This study is active but is not currently recruiting participants.
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Tanta, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exclusion criteria
titanium mesh with bone graft with delayed implant placement.
zirconium mesh with bone graft with delayed implant placement.
Time frame: 6 months
The patients will be followed up clinically postoperatively every 48-72 hours for the first week then after 2weeks then one month and then after 3 months then after 6 months for preserving: Presence/absence of mesh instability, flap dehiscence, exposed mesh, bone graft loss outside the flap, hematoma or laceration.
Time frame: 6,12 months
A CBCT will be done preoperatively (base line) and after 6 months and finally after 12 months postoperatively to assess dimensions of newly formed bone and its density.
Time frame: 6 months
The bone cores, left inside the trephine burs will be carefully rinsed with a cold 5% glucose solution. The specimens will be fixed in 10% formalin solution at pH 7.2 for a week and dehydrated with a graded series of alcohols. After the pre-infiltration treatment the bone cores will then be completely embedded in 100% resin until the specimens became transparent. Finally, the bone cores will be oriented and polymerized.
Tanta University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07475507
Alveolar Bone Loss, Bone Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05610748
Alveolar Bone Loss, Alveolar Ridge Enlargement
Ferrara, Italy
View Trial DetailsNCT05602493
Alveolar Bone Loss, Bone Diseases
Sant Cugat del Vallès, Barcelona, Spain
View Trial DetailsNCT03528330
Alveolar Bone Loss, Bone Diseases
Valencia, Spain
View Trial Details